EMCDDA Home
  • EN
Search

Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) in the framework of the Council Decision on new psychoactive substances

EMCDDA, Lisbon, May 2014

Publication type:

Risk assessments

Summary:

This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe), that was conducted by the Scientific Committee of the EMCDDA. Concerns over this hallucinogenic drug in the European Union led to an assessment of the health and social risks posed by the substance in April 2014.

Download as pdf (487Kb):

English (en)

Pages:

58

Price:

free

Page last updated: Tuesday, 27 May 2014